The plasmatic glucose level showed a decreasing trend in the first 4 months of therapy that stabilized in the range between 91-93 mg/L at week 52, in comparison to the mean value of 99.32 mg/L at baseline.
← all excerpts
Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes.
1
—
—